Ingredion Incorporated
INGRConsumer DefensiveNASDAQPackaged Foods
Scan Results
Daily timeframeIngredion Incorporated, together with its subsidiaries, engages in the manufacture and sale of sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and. The $6.38B market capitalization puts INGR squarely in mid-cap range for its industry. The company operates in Texture & Healthful Solutions; Food & Industrial IngredientsLATAM; and Food & Industrial IngredientsU.S./CANADA segments.
Market Cap
$6.38B
Beta
0.63
P/E (TTM)
9.72
P/E (Fwd)
8.71
EPS (TTM)
$10.40
EPS (Fwd)
$11.61
ROE
16.2%
ROA
7.9%
Cash
$918.0M
Total Debt
$1.82B
Free CF
$357.8M
52W Change
-26.3%
Annual Financials
Cash vs Debt
On the balance sheet, INGR has $918.0M in cash with $1.82B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $357.8M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 16.2% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.9% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $7.95B (2022) to $7.22B (2025).
The relatively low beta of 0.63 suggests INGR is a less volatile holding compared to the broader index. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Ingredion Incorporated and its sector.